ANDA 40603, held by Sun Pharma Canada. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40603 (Promethazine Hydrochloride), held by Sun Pharma Canada, was first approved by FDA on Oct 26, 2006, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 26, 2006 | Original application | Approved | None posted |
| Promethazine Hydrochloride12.5MG · suppository;rectal | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride25MG · suppository;rectal | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters